Follow this community via email Follow this community [ via ] [?]
Community

4889 Ben Franklin Technology Partners

www.benfranklin.org/


Ben Franklin Technology Partners is a statewide network that catalyzes entrepreneurship and technological innovation as drivers of economic growth. Operating regionally with four Partners strategically located throughout the Commonwealth, Ben Franklin provides emerging and existing businesses with access to risk capital, business and technology expertise, and expert third party resources. Ben Franklin’s investments, services and access to resources comprise a comprehensive support structure that helps emerging companies succeed, existing companies to innovate and grow, and supports the development of a vibrant entrepreneurial culture that is critical to sustainable growth.


The Latest Innovations
Penn State

18 JAN 12

The UGT2B10D67Y Gene Polymorphism as a Marker for Response to Olanzapine Treatment and Prevention of Side Effects

<p>We have discovered the enzymes responsible for <span class="caps">OLZ</span> gucuronidation. Since glucuronidation is a major mode of <span class="caps">OLZ</span> elimination from the body, a polymorphism in the genes responsible for glucuronidation could significantly impact <span class="cap...

Penn State

14 DEC 11

Up-Conversion Luminescent Coatings/Materials for Antimicrobial Applications

This invention describes a coating system adapted to absorb impinging wavelengths of radiation such that embedded particles are stimulated and emit ultraviolet wavelength energies sufficient for use in antimicrobial applications.

Lehigh University

27 AUG 11

Facile, High Yield Synthesis and Purification of CdS Quantum Dots from Optimized Strains of S. maltophilia

Quantum Dot Synthesis Description: A major barrier to the utilization of quantum dots (QDs) in commercial applications is the high cost associated with conventional chemical synthesis as well as the use of high temperatures and toxic solvents, thereby requiring specialized, exp...

Temple

05 AUG 11

Determining Oocyte Quality

<p>Background</p> <p>Globally, there are greater than 4 million babies born per year; over 250,000 of these are from assisted reproduction. In the US, the number of <span class="caps">ART</span> (Assisted Reproduction Technology) cycles has increased from approximately 83,000 in 1999 to 148,055....

Temple

05 AUG 11

Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof

The compounds of the present invention are in the form of peptides which possess anti-angiogenic activity. In all embodiments, the peptide may optionally comprise an amino-terminal and/or carboxy-terminal protecting group.

Temple

05 AUG 11

Biomarker for HIV-1 Infection

<p>This invention relates to measurements of monocyte CD 163, a monocyte/macrophage-specific scavenger receptor for hemoglobin-haptoglobin complex, mean fluorescence intensity and frequency measurements in blood which is an important surrogate marker for clinical management of <span class="caps">...

Temple

05 AUG 11

Fluorochemical Liquid Augmented Cryosurgery

<p>Perfluorochemical cryosurgery represents a fundamental platform technology that can be used for a wide variety of clinical cryosurgical applications. Perfluorochemical (<span class="caps">PFC</span>) liquids are biologically non-toxic substances that, in varying forms, are currently used as ar...

Temple

05 AUG 11

Obesity Controlling Method

<p>The invention is a method of treating obesity in which gastric emptying is slowed by narrowing the pyloric sphincter or pylorus, thus narrowing the lumen of the pylorus through which food must pass from the stomach into the small intestine. The invention comprises narrowing of the pyloric sphi...

Temple

05 AUG 11

Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5

<p>The present invention is based upon the discovery that antibodies which bind to HK domain 5 inhibit endothelial cell proliferation, tube formation and neovascularization. This activity confers upon such antibodies the ability to inhibit cytokine-driven angiogenesis in vivo. According to the as...

Temple

05 AUG 11

Process for Synthesis of Silane Dipeptide Analogs

<p>The present invention relates to the unexpected discovery that a substituted 1,2-oxasilolane may be efficiently converted to the dilithium salt of a substituted 3-hydroxypropylsilanol using lithium metal, which reductively cleaves the Si-O bond in high yields. The substituted 1,2-oxasilolane ...

See All 785 innovations


People
Icon_avatar Robert McGrath
Drexel University

 Innovations (0)

Icon_avatar Philip Caldwell
Drexel University

 Innovations (14)

Icon_avatar Alexey Melishchuk
Drexel University

 Innovations (8)

4181 Alan Seadler
Duquesne University of the Holy Spirit

 Innovations (0)

Icon_avatar Gaurav Rajani
Duquesne University of the Holy Spirit

 Innovations (0)


  See All People (18) »
Organizations
Followed By

Other Communities
4884
Massachusetts Technology Transfer Center (MTTC)
5171
Michigan Universities
6401
Singapore
7223
Toronto, Canada
7268
Clinical and Translational Science Awards (CTSA)
9138
Italy
14641
Europe
14611
Spain
14621
Middle East
17071
Easy Access IP

KiwiNet - New Zealand
Profile
Related Tags

Find more innovations


February 11, 2009

7,783 members 17,070 innovations 152 organizations

Browse

Scott Steele, coordinator of the CTSA-IP initiative and director of research alliances at the University of Rochester

"With more than 3,700 innovations from CTSA member institutions already on the iBridge Network, we're garnering worldwide exposure for the breakthroughs our researchers are accomplishing while moving toward our goal of increasing human health through clinical and translational research."  read more...